|
MRPS18B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.603400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.774099999998E-05 |
| Normal-vs-Stage2 |
7.366400E-01 |
| Normal-vs-Stage3 |
8.04600000000599E-05 |
| Normal-vs-Stage4 |
4.32120000000147E-05 |
| Stage1-vs-Stage2 |
1.138040E-03 |
| Stage1-vs-Stage3 |
4.850800E-01 |
| Stage1-vs-Stage4 |
2.771800E-01 |
| Stage2-vs-Stage3 |
2.004500E-04 |
| Stage2-vs-Stage4 |
4.601100E-04 |
| Stage3-vs-Stage4 |
6.458400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.0466999999913E-05 |
| Normal-vs-AfricanAmerican |
2.877700E-03 |
| Normal-vs-Asian |
1.591820E-02 |
| Caucasian-vs-AfricanAmerican |
8.529600E-01 |
| Caucasian-vs-Asian |
1.746610E-01 |
| AfricanAmerican-vs-Asian |
2.584200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.369710E-04 |
| Normal-vs-Female |
4.009200E-04 |
| Male-vs-Female |
4.426800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.22180000003713E-06 |
| Normal-vs-Age(41-60Yrs) |
2.375400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.061790E-03 |
| Normal-vs-Age(81-100Yrs) |
1.977960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.952100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.066800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.910200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.798800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.109800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.882200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.561400E-01 |
| Classical-VS-Follicular |
7.843100E-03 |
| Classical-VS-Other |
9.077600E-01 |
| Classical-VS-Normal |
2.91549999997809E-06 |
| Tall-VS-Follicular |
1.887910E-02 |
| Tall-VS-Other |
9.848600E-01 |
| Tall-VS-Normal |
4.032100E-04 |
| Follicular-VS-Other |
3.490800E-01 |
| Follicular-VS-Normal |
2.222800E-01 |
| Other-VS-Normal |
2.343200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.175400E-03 |
| Normal-vs-N1 |
2.89320000179671E-08 |
| N0-vs-N1 |
1.447460E-04 |
|
|
